Beijing Research Institute of Chinese Medicine, Beijing University of Chinese Medicine, Beijing, China.
J Enzyme Inhib Med Chem. 2023 Dec;38(1):166-175. doi: 10.1080/14756366.2022.2136173.
Although various dual-target tubulin inhibitors have been designed and synthesised, no dual tubulin-NEDDylation inhibitors as antiproliferative agents were reported so far. In this work, a series of trimethoxyphenyl analogues as potential dual tubulin-NEDDylation inhibitors were synthesised and evaluated for their antiproliferative activity. Among them, compound exhibited the most potent inhibitory activity with IC values of 1.17, 2.48, and 1.47 μM against HepG2, PC3, and MCF7 cells, respectively. In addition, it displayed the potent inhibitory activity against tubulin with an IC value of 2.40 μM and obviously inhibited tubulin polymerisation in HepG2 cells. Furthermore, inhibited NEDDylation by a ATP-dependent manner. Molecular docking studies revealed that the methoxy group and dithiocarbamate group of could form hydrogen bonds with residues of tubulin and E1 NEDD8-activating enzyme (NAE). These results suggested that compound was a dual tubulin-NEDDylation inhibitor with antiproliferative activity.
虽然已经设计和合成了各种双靶标微管抑制剂,但到目前为止,还没有报道将双微管-NEDDylation 抑制剂作为抗增殖剂。在这项工作中,合成了一系列三甲氧基苯基类似物作为潜在的双微管-NEDDylation 抑制剂,并对其进行了抗增殖活性评价。其中,化合物 对 HepG2、PC3 和 MCF7 细胞的抑制活性最强,IC 值分别为 1.17、2.48 和 1.47 μM。此外,它对微管具有很强的抑制活性,IC 值为 2.40 μM,并明显抑制 HepG2 细胞中的微管聚合。此外, 通过 ATP 依赖性方式抑制 NEDDylation。分子对接研究表明, 的甲氧基和二硫代氨基甲酸盐基团可以与微管和 E1 NEDD8-激活酶 (NAE) 的残基形成氢键。这些结果表明,化合物 是一种具有抗增殖活性的双微管-NEDDylation 抑制剂。